GLENDA CARDONA: Open Payments
NPI 1639478274 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$833 in 25 payments from 8 companies in 2025. Trend: 2023 $762 · 2024 $904 · 2025 $833
Food & beverage: $744Education: $89
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $420 |
| GENZYME CORPORATION | 12 | $189 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| SANOFI-AVENTIS U.S. LLC | 1 | $55 |
| CSL Behring | 1 | $36 |
| Amgen Inc. | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
Products named: DUPIXENT, TEZSPIRE, AIRSUPRA, TRELEGY ELLIPTA, Haegarda, Rhapsido, EBGLYSS, BREZTRI.
Industry payments across TX — which companies pay providers there.
